Publication:
KMT2B-Related Dystonia: Challenges in Diagnosis and Treatment

dc.authorscopusid7007041106
dc.authorscopusid57215863607
dc.authorscopusid57202990102
dc.authorscopusid57191877626
dc.authorwosidCeylan, Ahmet Cevdet/Aaa-6601-2021
dc.authorwosidYayıcı Köken, Özlem/Aaa-1050-2022
dc.authorwosidToptaş, Özge/Agn-1838-2022
dc.authorwosidYayıcı Köken, Özlem/Aaa-1050-2022
dc.contributor.authorAksoy, Ayse
dc.contributor.authorKoken, Ozlem Yayici
dc.contributor.authorCeylan, Ahmet Cevdet
dc.contributor.authorDedeoglu, Ozge Toptas
dc.contributor.authorIDDedeoglu, Özge/0000-0002-7492-5255
dc.contributor.authorIDYayıcı Köken, Özlem/0000-0003-2112-8284
dc.date.accessioned2025-12-11T01:23:31Z
dc.date.issued2021
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Aksoy, Ayse] Samsun Ondokuz Mayis Univ, Dept Pediat Neurol, Samsun, Turkey; [Koken, Ozlem Yayici] Ankara City Hosp, Dept Pediat Neurol, Ankara, Turkey; [Ceylan, Ahmet Cevdet] Yildirim Beyazit Univ, Ankara City Hosp, cDept Mol Biol & Genet, Ankara, Turkey; [Dedeoglu, Ozge Toptas] Mardin State Hosp, Dept Pediat Neurol, Ankara, Turkeyen_US
dc.descriptionDedeoglu, Özge/0000-0002-7492-5255; Yayıcı Köken, Özlem/0000-0003-2112-8284;en_US
dc.description.abstractIn this study, we report the first known Turkish case of a novel nonsense mutation c.2453dupT (p.M818fs*28) in the KMT2B (NM_014727.2) gene diagnosed in a male patient with KMT2B-related dystonia (DYT-KMT2B, DYT-28, Dystonia*-28), which is a complex, childhood-onset, progressive, hereditary dystonia. The patient, who is followed up from 9 to 13 years of age, had dysmorphic features, developmental delay, short stature, and microcephaly, in addition to focal dystonia and hemichorea (in the right and left lower extremities). Generalized dystonia involving bulbar and cervical muscles, in addition to dystonic cramps, myoclonus, and hemiballismus, were also observed during the course of the follow-up. While he was able to perform basic functions like eating, climbing stairs, walking, and writing with the aid of levodopa and trihexyphenidyl treatment, his clinical status gradually deteriorated secondary to progressive generalized dystonia in the 4-year follow-up. Deep brain stimulation has been shown to be effective in several patients which could be the next preferred treatment for the patient.en_US
dc.description.woscitationindexScience Citation Index Expanded
dc.identifier.doi10.1159/000518974
dc.identifier.issn1661-8769
dc.identifier.issn1661-8777
dc.identifier.pmid35418819
dc.identifier.scopus2-s2.0-85120742267
dc.identifier.scopusqualityQ4
dc.identifier.urihttps://doi.org/10.1159/000518974
dc.identifier.urihttps://hdl.handle.net/20.500.12712/43379
dc.identifier.wosWOS:000721625000001
dc.identifier.wosqualityQ4
dc.language.isoenen_US
dc.publisherKargeren_US
dc.relation.ispartofMolecular Syndromologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectKMT2Ben_US
dc.subjectChildhood Dystoniaen_US
dc.subjectMovement Disorderen_US
dc.subjectExome Sequencingen_US
dc.subjectNovel Mutationen_US
dc.titleKMT2B-Related Dystonia: Challenges in Diagnosis and Treatmenten_US
dc.typeArticleen_US
dspace.entity.typePublication

Files